Lacoste Sandrine A, Gagnon Vanessa, Béliveau François, Lavallée Sylvie, Collin Vanessa, Hébert Josée
Quebec Leukemia Cell Bank, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada.
Cytogenetics Laboratory, Maisonneuve-Rosemont Hospital, Montréal, QC H1T 2M4, Canada.
Cancers (Basel). 2024 Dec 14;16(24):4171. doi: 10.3390/cancers16244171.
rearrangements are major genetic entities in the classification of acute myeloid leukemias (AMLs), but their diverse and frequently cryptic nature makes their detection and characterization challenging. Karyotypic anomalies at the locus and/or abnormal Fluorescence in situ hybridization (FISH) results strongly indicate a fusion, but the identification of the translocation partner gene often requires further investigation. partial tandem duplications (PTDs), on the other hand, are undetectable by standard cytogenetics methods. We herein report the optical genome mapping (OGM) analysis of 38 AML samples: 12 cryptic/hard-to-characterize fusions, 20 -PTDs and 6 cases with no anomaly. In all the fusion cases, the rearrangement between 5' and the 3'partner gene was identified as a translocation t(v;11q23.3)(v;118479068), and the analysis of co-occurring variants elucidated the formation of the rearrangement. The variants detected in the -PTD cases were surprisingly diverse. Combined with RNAseq data, OGM analysis identified 9 distinct in-frame -PTD variants among the 20 cases analyzed. With the clinical development of menin inhibitors for the treatment of patients with -rearranged acute leukemias, the characterization of these rearrangements is of utmost importance. Our results suggest that OGM is a promising tool for accurate genetic diagnosis in this context.
重排是急性髓系白血病(AML)分类中的主要遗传实体,但其多样且常常隐匿的性质使得它们的检测和特征描述具有挑战性。该位点的核型异常和/或异常的荧光原位杂交(FISH)结果强烈提示存在融合,但易位伙伴基因的鉴定通常需要进一步研究。另一方面,标准细胞遗传学方法无法检测到部分串联重复(PTD)。我们在此报告了对38例AML样本的光学基因组图谱(OGM)分析:12例隐匿性/难以特征化的融合、20例-PTD以及6例无异常的病例。在所有融合病例中,5'与3'伙伴基因之间的重排被鉴定为易位t(v;11q23.3)(v;118479068),并且对共发生变异的分析阐明了重排的形成。在-PTD病例中检测到的变异令人惊讶地多样。结合RNAseq数据,OGM分析在20例分析病例中鉴定出9种不同的框内-PTD变异。随着用于治疗重排急性白血病患者的脑膜瘤抑制剂的临床开发,这些重排的特征描述至关重要。我们的结果表明,在这种情况下,OGM是一种用于准确基因诊断的有前景的工具。